0001740279-18-000002.txt : 20180920 0001740279-18-000002.hdr.sgml : 20180920 20180920160526 ACCESSION NUMBER: 0001740279-18-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180920 DATE AS OF CHANGE: 20180920 EFFECTIVENESS DATE: 20180920 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Incysus Therapeutics, Inc. CENTRAL INDEX KEY: 0001740279 IRS NUMBER: 825462585 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-312981 FILM NUMBER: 181079485 BUSINESS ADDRESS: STREET 1: 79 MADISON AVENUE, 2ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: (646) 820-8474 MAIL ADDRESS: STREET 1: 79 MADISON AVENUE, 2ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10016 D/A 1 primary_doc.xml X0708 D/A LIVE 0001740279 Incysus Therapeutics, Inc. 79 MADISON AVENUE, 2ND FLOOR NEW YORK NY NEW YORK 10016 (646) 820-8474 DELAWARE None None Corporation true 2018 William Ho 79 Madison Avenue New York NY NEW YORK 10016 Executive Officer Director Thomas Cirrito 79 Madison Avenue New York NY NEW YORK 10016 Director Travis Whitfill 79 Madison Avenue New York NY NEW YORK 10016 Director Biotechnology Decline to Disclose 06b true 0001740279-18-000001 2018-05-07 false true false 0 10000000 8812156 1187844 false 25 0 0 0 false Incysus Therapeutics, Inc. /s/ William Ho William Ho Chief Executive Officer 2018-09-20